Amylin, Takeda in obesity deal

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) partnered with Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) to co-develop and commercialize

Read the full 152 word article

User Sign In